Preemptive stenting of the left pulmonary artery during comprehensive stage 2 procedure does not influence Fontan candidacy

• Published in: JTCVS open 2023-03, Vol.13, p.330-343
• Main Authors: Carrillo, Sergio A., Best, Cameron, Hersey, Diane, Texter, Karen, McConnell, Patrick I., Boe, Brian, Galantowicz, Mark
• Format: Article
• Language: English
• Subjects: Congenital: Fontan; Fontan; HLHS; hybrid palliation; preemptive stenting; pulmonary artery stenting
• ISSN: 2666-2736; 2666-2736
• DOI: 10.1016/j.xjon.2022.11.007

Pulmonary artery reconstruction during comprehensive stage 2 (CS2) procedure can be challenging. Since 2017, we have employed preemptive left pulmonary artery (LPA) stenting. We hypothesized that LPA stenting promotes adequate growth and without compromising Fontan candidacy. Herewith, we report our midterm results. From 2002 to 2020, 159 patients underwent CS2. Patients were divided as follows: no stent (n = 122; Group 1) and perioperative LPA stent (n = 37; Group 2). Group 2 was subdivided according to unplanned stent (n = 17; Group 2a) or preemptive stent (n = 20; Group 2b). Relevant perioperative data was reviewed. Nonparametric statistics were utilized. Median age and weight at surgery and hospital length of stay after CS2 did not differ between groups. Median cardiopulmonary bypass and crossclamp times were significantly greater in Group 1 (265 vs 243 minutes [P = .021] and 46 vs 26 minutes [P = .008]). In-hospital mortality was similar between Groups 1 and 2 (9.0% vs 18.9%, respectively [P = .1348]). Group 2b demonstrated a superior survival compared to Group 2a (P = .0335) but not Group 1 (P > .9999). Preemptive stenting significantly increased median hilar LPA diameter at CS2 exit angiogram compared with no stenting (P